In this study we explore the mechanisms by which a double mutation (E59D/D75Y) in cardiac troponin C (CTnC) associated with dilated cardiomyopathy reduces the Ca 2؉ -activated maximal tension of cardiac muscle. Studying the single mutants (i.e. E59D or D75Y) indicates that D75Y, but not E59D, causes a reduction in the calcium affinity of CTnC in troponin complex, regulated thin filaments (RTF), and the Ca 2؉ sensitivity of contraction and ATPase in cardiac muscle preparations. However, both D75Y and E59D are required to reduce the actomyosin ATPase activity and maximal force in muscle fibers, indicating that E59D enhances the effects of D75Y. Part of the reduction in force/ATPase may be due to a defect in the interactions between CTnC and cardiac troponin T, which are known to be necessary for ATPase activation. An additional mechanism for the reduction in force/ATPase comes from measurements of the binding stoichiometry of myosin subfragment-1 (S-1) to the RTF. Using wild type RTFs, 4.8 mol S-1 was bound per mol filament (seven actins), whereas with E59D/D75Y RTFs, the number of binding sites was reduced by ϳ23% to 3.7. Altogether, these results suggest that the reduction in force and ATPase activation is possibly due to a thin filament conformation that promotes fewer accessible S-1-binding sites. In the absence of any family segregation data, the functional results presented here support the concept that this is likely a dilated cardiomyopathy-causing mutation.
There are numerous findings that suggest a hallmark of mutations in the regulated thin filament (RTF) 4 is to alter the Ca 2ϩ regulation of cardiac muscle contraction (1, 2) . In general, mutations in the RTF associated with dilated cardiomyopathy (DCM) tend to decrease the Ca 2ϩ sensitivity of contraction, whereas mutations associated with hypertrophic and restrictive cardiomyopathies tend to increase the Ca 2ϩ sensitivity. Some of these mutations, notably in cardiac troponin T (CTnT), can also alter the maximal force generating capabilities of muscle (1, 3, 4) , suggesting that a subset of RTF mutants can also alter the number and/or efficiency of attached myosin heads at all Ca 2ϩ concentrations. Nevertheless, it is still unclear how and why some mutants alter the maximal force generating properties of muscle, whereas others do not.
Cardiac contraction is regulated by the RTF, which contains cardiac troponin (CTn), tropomyosin (Tm), and F-actin. CTn consists of three interacting subunits: troponin C (CTnC) is the Ca 2ϩ -binding subunit, troponin I (CTnI) is the inhibitory subunit, and CTnT is the Tm-binding subunit. Cardiac contraction occurs upon Ca 2ϩ binding to CTnC, which promotes CTn-Tm translocation. This allows for the interaction between actin and myosin and the subsequent generation of tension (5) . (6) .
Currently, six cardiomyopathy-linked mutations in CTnC exist that have been characterized in vitro (7) (8) (9) (10) (11) (12) . However, the first potential DCM mutation in CTnC was a double mutation at residues 59 and 75 (E59D/D75Y) in a patient with idiopathic DCM (13) . No pedigree information is available to assess the segregation of this mutation with the disease; therefore, relevant functional studies are critical in determining the significance and molecular impact of this mutation.
In a recent report, the expression of the individual mutants in cardiomyocytes showed that the D75Y mutant was able to recapitulate the E59D/D75Y phenotype, which impaired the myofilament response to activation (12) . In contrast, our studies found that the D75Y and E59D/D75Y mutants differentially affect the force generating and ATPase activation properties of skinned cardiac muscle.
Utilizing NMR techniques, one group reported that in the presence of Ca 2ϩ , the affinity of the N-domain of E59D/D75Y-CTnC for the CTnI switch peptide (147-163) was different when compared with the WT-CTnC control (11) . Currently, it is unknown how CTnI will influence the maximal ATPase activity and force generating capabilities of a more intact system. Therefore, to elucidate some of the mechanisms underlying the decrease in contractile force, we focused on the ability of these mutations to affect the ATPase activities of skinned cardiac myofibrils (CMF) and reconstituted actomyosin (RAM).
The fluorescent probe 2-(4Ј-(iodoacetamido)anilino)naphthalene-6-sulfonic acid (IAANS) covalently bound to CTnC was used to correlate the effects of Ca 2ϩ binding and myofilament protein interactions on the structure of CTnC (14) . This enables the comparisons of apparent CTnC Ca 2ϩ affinities measured by fluorescence in CTnC, CTn, and RTF with measurements of tension and ATPase activity in skinned muscle preparations because all are indirect measurements of Ca 2ϩ binding to the regulatory site of CTnC. Our results indicate that the reduction in contractile force arising from the double mutant is accompanied by a decrease in CTnC Ca 2ϩ affinity and a thin filament conformation that reduces the number and/or accessibility of myosin subfragment-1 (S-1)-binding sites. (14) . The expression and purification of human CTnC, CTnI, and CTnT followed previous methods (7) . Porcine CMF, Tm, and myosin were prepared from left ventricles (7). Myosin subfragment-1 was prepared from rabbit skeletal myosin (15) . F-actin was prepared from rabbit skeletal acetone powder (16) .
EXPERIMENTAL PROCEDURES
Multiprotein Complex Formation-Formation of fluorescent and nonfluorescent binary and ternary CTn complexes were prepared using standard methods (7, 14) . CTnC(C84) IA -labeled RTF (F-actin:Tm:CTn in a 7:1:1 ratio) were prepared as described previously (7) .
Determination of Apparent Ca 2ϩ Affinities-Ca 2ϩ binding was measured by monitoring the peak emission intensity (448 nm) from the IAANS-labeled proteins in standard buffer as described previously (7) . The data were fitted to a version of the Hill equation using SigmaPlot 11.0 software, and the Ca 2ϩ affinities were reported within this manuscript as pCa 50 values (Ϫlog [Ca 2ϩ ] free at which 50% of the maximal response is observed). In cases of biphasic binding, the data were fit to Equation 1,
where Y is the fluorescence intensity, S 1 and S 2 are the contributions of each class of site to the fluorescence, K d1 and K d2 are the dissociation constants for each class of site, and n 1 and n 2 are the respective Hill coefficients.
Binding of Subfragment-1 with RTFs-Labeled RTFs were prepared as above except that the RTF pellets were resuspended in buffer containing 150 mmol/liter KCl, 50 mmol/liter MOPS, 1.25 mmol/liter MgCl 2 , 0.5 mmol/liter EGTA, 1 mmol/ liter nitrilotriacetic acid, 1 mmol/liter dithiothreitol, pH 7.0 ( ϭ 183). The S-1 was dialyzed in the same buffer before use. S-1 was incrementally added to a cuvette containing 2 ml of CTnC(C84) IA -labeled RTFs (50 nmol/liter) at 23°C with constant mixing. Each addition ([S-1] final ϭ 500 nmol/liter) was followed by a 2-min pause before the solution was excited at 330 nm and the emission (445 nm) intensity was recorded. Each signal reading was averaged from 750 points recorded over 10 s. The dilution never exceeded 3.5% (at the final S-1 addition), and the averaged signals were corrected. The averaged baseline signal intensity (in the absence of S-1) was subtracted from the averaged signal intensities and fit to Equation 2, which is a solution for a quadratic equation (17),
where E o is the concentration of RTF, which is held constant; X i is the concentration of S-1, which is varied; and ⌬F i is the base line-subtracted fluorescence signal after the ith addition of S-1. n, the number of S-1-binding sites; K d , the dissociation constant; and ⌬F max , the base line-subtracted maximum fluorescence signal, can all be obtained from the fit.
Reconstituted Actomyosin ATPase Assays-F-actin, Tm, and myosin were mixed together to prepare RAM, followed by the addition of preformed CTn or CTnC-CTnI binary complexes to assess the RAM Mg 2ϩ -ATPase activity as described previously (7) . Ca 2ϩ -activated Cardiac Myofibrillar ATPase Assays-trans-1,2-Cyclohexane-N,N,NЈ,NЈ-tetraacetic acid (CDTA) treatment of CMF, CTnC (WT and mutant) reconstitution, and subsequent determination of the Ca 2ϩ sensitivity of CMF ATPase activation followed previous methods (7) . The data were fitted to the Hill equation using the software of SigmaPlot 10.0.
Skinned Fiber Preparations-Skinned porcine papillary fibers were prepared using established protocols (7) . Briefly, the skinned cardiac fibers were mounted using stainless steel clips to a force transducer and immersed in a relaxation solution (pCa 8 ], 15 mmol/liter creatine phosphate, 15 units/ml phosphocreatine kinase, pH 7.0, and between 33.6 and 47.9 mmol/liter KPr to achieve a constant ionic strength of 150 mmol/liter in all solutions. The fiber slack was removed until tension developed, and then the fiber was stretched 1.2ϫ its length. This results in estimated sarcomere lengths between 2.2 and 2.3 m. The various pCa solutions were prepared using the binding constants at 20°C (18) . The contraction solution (pCa 4.0) was the same composition as the pCa 8.0 solution, except that the free Ca 2ϩ concentration was 10 Ϫ4 mol/liter and was used to measure the initial force. Endogenous CTnC was extracted with 5 mmol/ liter CDTA (pH 8.4) until the fibers developed ϳ20% (1.5-2.0 h) of the initial tension (residual tension) in pCa 4.0 before reconstitution with CTnC (WT or mutant). The Ca 2ϩ dependence of tension was tested in solutions containing intermediate concentrations of Ca 2ϩ . The data were analyzed as above.
Muscle Fiber CTnC Quantification-Five muscle fibers resulting in ϳ20% residual force after CDTA treatment had their proteins separated by SDS-PAGE and transferred to polyvinylidene difluoride membranes. Anti-human cardiac troponin C, clone 7b9 (Research Diagnostics, Inc., Concord, MA), and anti-human myosin light chain I (essential light chain) (Accurate Chemical, Westbury, NY) were diluted 1:500 and 1:40,000, respectively, for primary detection. Secondary detection for quantitative Western blots was performed with goat anti-mouse Alexa-680 (1:4000) from Rockland Immunologicals (Gilbertsville, PA). Visualization and quantification of gel bands was performed with the Odyssey infrared imaging system (LI-Cor Biosystems, Homburg, Germany). Normalization of gel bands was accomplished by ratiometric analysis using essential light chain as a loading control. The changes in CTnC content from the CDTA-treated fiber were estimated by comparing the ratios of CTnC/essential light chain between the experimental and control fibers.
Preparation of Buffered Calcium Solutions-Methods for solving the free and bound metal ion equilibria in our solutions were provided for by the computer program pCa Calculator (18) .
Statistical Analysis-The data are expressed as the averages of four to six experiments Ϯ S.D. (unless otherwise stated). Significant differences were determined using a one-way analysis of variance (SigmaPlot version 11.0), with significance defined as p Ͻ 0.05.
RESULTS

Ca
2ϩ Sensitivity of Tension in Skinned Cardiac Fibers-Skinned cardiac papillary muscle had its endogenous CTnC extracted by treatment with CDTA and then reconstituted back with recombinant CTnCs (WT or mutant). Fig. 1 (A and B) illustrates the effects of mutant CTnC reconstitution on the Ca 2ϩ dependence of force development. Incorporation of E59D/D75Y-CTnC into CTnC-depleted fibers significantly decreased the Ca 2ϩ sensitivity of tension 0.1 pCa units when compared with the WT control (Table 1) . Additionally, Fig. 1C shows that the reconstitution of E59D/D75Y-CTnC into fibers only restored 55% of the "initial" (before CDTA treatment) maximal tension in comparison with the 75% that is restored by the WT-CTnC. After CDTA treatment, the residual tension in pCa 4 (free [Ca 2ϩ ] ϭ 10 Ϫ4 M) for all fibers was ϳ20% and not statistically different among each group (Fig. 1C) . This implies that the remaining Ca 2ϩ -activated tension in each group after CDTA treatment is attributed to the endogenous CTnC that remains. Western blot analysis shows that 14.0 Ϯ 5.3% of the endogenous CTnC remains after CDTA treatment, and incubation of fibers with WT or mutant CTnC is able to restore the full complement of CTnC back into the muscle fibers (Fig. 1D ). These results indicate that the drop in maximal tension observed in fibers reconstituted with E59D/D75Y-CTnC is due to an inactivation property of this mutant rather than the lack of its incorporation back into the thin filament. When E59D or D75Y-CTnC is reconstituted into the CDTAtreated fibers, the maximal restored tensions are not statistically different from the WT control (Fig. 1C) . However, in Fig.  1B , only D75Y-CTnC has the ability to significantly decrease the Ca 2ϩ sensitivity of tension (⌬pCa 50 ϭ Ϫ0.08). The pCa 50 and n H values of fibers reconstituted with D75Y-CTnC are statistically insignificant in comparison with the values derived from the double mutant reconstituted fibers (summarized in Table 1) .
Effect of CTnC Reconstitution on CMF and RAM ATPase Activity- Fig. 2 (A and B) shows the Ca 2ϩ sensitivities of ATPase activation from CDTA-treated CMF that have been reconstituted with WT or mutant CTnCs. The CDTA-treated myofibrils are essentially inactivated at all Ca 2ϩ concentrations (data not shown). After CTnC (WT or mutant) reconstitution, all myofibrillar ATPase activities are similarly inhibited in pCa 8.0 (Fig. 2, A and B) . However, Fig. 2A shows that the maximal ATPase levels (in pCa 4.5) are not fully restored in the presence of E59D/D75-CTnC. A 3-fold ATPase activation is observed in comparison with the 4-fold activation seen in the WT-CTnC reconstituted myofibrils ( Table 2 ). The data obtained from this figure are normalized (Fig. 2, A and B, insets) to better illustrate the changes in the apparent Ca 2ϩ affinity caused by the mutants (summarized in Table 2 ).
When E59D or D75Y-CTnC is reconstituted into the CDTAtreated CMF, the maximal restored ATPase activities are not statistically different from the WT-CTnC reconstituted CMF (Fig. 2B and Table 2 ). However, significant differences in the pCa 50 of ATPase activation occur for the E59D and D75Y reconstituted CMF in opposite directions (⌬pCa 50 ϭ ϩ0.16 and Ϫ0.19, respectively). Although the pCa 50 of ATPase activation from CMF reconstituted with D75Y and E59D/D75Y-CTnC are statistically different from each other, they both show significant reductions in their Ca 2ϩ sensitivities when compared with the WT control.
F-actin, tropomyosin, and myosin were mixed together to prepare reconstituted actomyosin. Then preformed CTn complexes prepared with WT or mutant CTnCs were added to determine their abilities to affect the inhibition and activation of RAM Mg 2ϩ -ATPase activity. The specific ATPase activity of "unregulated" actin-Tm-myosin (i.e. in the absence of CTn) is considered 100% in our calculations ( Table 2 ). Table 2 ). Fig. 2D shows the effects of preformed CTnC-CTnI binary complexes prepared with WT or E59D/D75Y-CTnC on their abilities to affect CTnI inhibition (ϪCa 2ϩ ) and neutralization (ϩCa 2ϩ ) of RAM Mg 2ϩ -ATPase activity. The specific ATPase activity of unregulated actin-Tm-myosin is considered 100% in our calculations. RAM prepared with binary complexes containing WT and E59D/D75Y-CTnC are not statistically different from each other in their abilities to inhibit (ϪCa 2ϩ ) the ATPase activity or neutralize (ϩCa 2ϩ ) the CTnI-based inhibition.
Determining the Apparent Ca 2ϩ Affinity from IAANS-labeled Proteins- Fig. 3A represents the Ca 2ϩ -dependent changes in fluorescence arising from WT and mutant CTnC IA -labeled proteins. Because the curves in Fig. 3A are biphasic, the data are fit to a modified Hill equation (see "Experimental Procedures") to account for two classes of binding sites with the pCa 50 values and Hill coefficients summarized in Fig. 3B shows the Ca 2ϩ -dependent changes in fluorescence from CTnC-CTnI binary complexes prepared with WT, E59D/ D75Y, and D75Y-CTnC(C84) IA . The WT binary complex increases its fluorescence when the free Ca 2ϩ rises from pCa 8.0 to 5.0 with a pCa 50 of 6.24. In comparison, the Ca 2ϩ affinities of the E59D/D75Y and D75Y binary complexes are significantly reduced (⌬pCa 50 ϭ Ϫ0.65 and Ϫ0.74, respectively). The pCa 50 values of E59D/D75Y and D75Y binary complexes are statistically different from each other. Fig. 3C shows the Ca 2ϩ -dependent changes in fluorescence from labeled CTn (CTn IA ) prepared with WT, E59D/D75Y, E59D, and D75Y-CTnC IA . In comparison with WT-CTn IA , the Ca 2ϩ affinities of E59D/D75Y and D75Y-CTn IA are significantly reduced (⌬pCa 50 ϭ Ϫ0.9 and Ϫ0.85, respectively). Moreover, significant changes in the Hill coefficient that accompany these large shifts in pCa 50 are indicative of irregularities in the cooperative events that regulate CTnC Ca 2ϩ binding in the ternary state. The Ca 2ϩ affinity of E59D-CTn IA is significantly decreased, but to a much lesser extent than E59D/D75Y-CTn IA . Fig. 3D shows the Ca 2ϩ -dependent changes in fluorescence from labeled RTFs prepared with WT, E59D/D75Y, and E59D- CTnC(C84) IA . The WT and E59D-RTF fluorescence intensities increase ϳ1.65-fold when the free Ca 2ϩ is raised from pCa 7.8 to 4.4 with pCa 50 values of 6.12 and 6.17, respectively. In the same pCa range, the E59D/D75Y-RTF fluorescence increases 1.25-fold with a marked reduction in Ca 2ϩ affinity (⌬pCa 50 ϭ Ϫ0.36). The data from Fig. 3 are summarized in Table 3 . 
DISCUSSION
Our results indicate that the E59D/D75Y mutation directly affects the Ca 2ϩ binding properties of CTnC and the transmission of force production. Although both mutations are located in the N terminus of CTnC, a miscommunication between the two domains exists because we observe reductions in the Ca 2ϩ affinities for the Ca 2ϩ -Mg 2ϩ and Ca 2ϩ -specific sites measured by fluorescence in the isolated CTnC (Table 3) .
Measuring Ca 2ϩ binding to E59D/D75Y-CTnC interacting in complex and in RTFs continues to show significant reduc- tions in the Ca 2ϩ affinity at every hierarchal level of the thin filament (Table 3) . However, the shifts in Ca 2ϩ affinity alone cannot account for the observed drops in maximal tension (Table 1) and ATPase activation ( Table 2 ). This conclusion is based upon several findings reported herein. First, E59D/ D75Y-CTnC is incapable of restoring the maximal tension and ATPase activities of skinned muscle under saturating Ca 2ϩ concentrations (Tables 1 and 2 ). Second, RAM prepared with E59D/D75Y-CTn is incapable of activating the ATPase beyond the levels of unregulated actin-Tm-myosin (Fig. 2C) . Third, the Ca 2ϩ affinities, Hill coefficients, and Ca 2ϩ -dependent structural changes of D75Y and E59D/D75-CTnC are indistinguishable when measured in CTn (Table 3 and Fig. 3) ; however, when the mutants are incorporated into skinned muscle, only the double mutant is capable of reducing the maximal tension and ATPase activity. Altogether, these findings indicate that in addition to decreasing the myofilament Ca 2ϩ sensitivity, additional molecular mechanisms exist that reduce the force generating capabilities of muscle containing the double mutant.
The changes in E59D/D75Y-CTnC Ca 2ϩ affinity are caused by the D75Y mutation. This premise is based on other reports (12) and ours, which show that the apparent Ca 2ϩ affinities of D75Y-CTnC in the isolated state, in complex, and in skinned muscle preparations are similar to the Ca 2ϩ affinities measured from the parent double mutant (Tables 1-3 ). However, both mutations (i.e. E59D and D75Y) are required to reduce the maximal CMF ATPase activation and force of skinned fibers. This is in contrast to previous reports showing that the D75Y mutant is capable of recapitulating the double mutant phenotype (12) .
Incorporation of only E59D-CTnC into labeled RTFs (Table  3) and CMF (Table 2 ) increases the apparent CTnC Ca 2ϩ affinity, whereas when D75Y only is present in these preparations, it decreases the apparent Ca 2ϩ affinities without affecting the maximal force and ATPase. Although insignificant, a similar trend is seen in the E59D-CTnC reconstituted muscle fibers (Table 1) . These results suggest that although E59D-CTnC may sensitize the myofilament, it does not contribute to the changes in myofilament Ca 2ϩ sensitivity when the double mutation is present. Rather, these results suggest that E59D enhances the effects of D75Y such that together the mutations synergistically lower the maximal force and ATPase activation of muscle.
Although it has been shown by NMR that the N-domain of E59D/D75Y-CTnC may have different affinities for the CTnI switch region (residues 147-163) (11), the double mutant CTnC appears to interact normally with CTnI in binary complex because it is capable of neutralizing the CTnI-based ATPase inhibition (Fig. 2D) . One interpretation of the NMR data is that the double mutant affects the way CTnI cooperatively regulates the Ca 2ϩ affinity of the CTnC regulatory site, thereby augmenting the Ca 2ϩ sensitivity of force production. Previous investigators showed that although TnI inhibition could be neutralized by TnC, the only time that ATPase activation was observed beyond unregulated levels was in the presence of TnT and Ca 2ϩ (19) . This indicated that ATPase activation is a property governed by a Ca 2ϩ -dependent TnC and TnT interaction responsible for the transmission of force. This premise is also supported by our data in Fig. 2D , which shows that the WT and double mutant binary complexes are unable to activate the ATPase beyond unregulated levels when CTnT is absent. However, the Mg 2ϩ -ATPase activity of RAM prepared with E59D/D75Y-CTn never exceeds the levels of actomyosin and Tm alone in the presence of Ca 2ϩ (Fig. 2C ), suggesting that a diminished TnCTnT interaction may exist that could be largely responsible for the Mg 2ϩ -ATPase inactivation. The current results indicate that a failure to activate the ATPase activity beyond unregulated levels may be responsible for the lower force observed at all Ca 2ϩ concentrations. We rationalized that because the double mutant is capable of neutralizing the CTnI-based inhibition (Fig. 2D) , other mechanisms independent of CTnI could exist that decrease the number of attached myosin motors. Therefore, we measured the total number of accessible S-1 actin-binding sites in the absence of Ca 2ϩ and ATP at physiological ionic strength. We show that the S-1 binding stoichiometry within cardiac RTFs has similar numbers of binding sites obtained when heavy meromyosin binds to skeletal thin filaments (20) and myofibrils (21) . Fig. 4 shows that the S-1 affinity does not change significantly in the presence of E59D/D75Y-CTnC(C84) IA ; rather the combined fits indicate that fewer binding sites are available when RTFs are prepared with the double mutant (3.7 S-1/filament) in comparison with the WT control (4.8 S-1/filament). It may be a striking coincidence, but ϳ23% fewer S-1 sites are available, and ϳ25% of the maximal tension and CMF ATPase activation is lost. Although rigor cross-bridges (A⅐M) make up a small fraction of the various strongly attached cross-bridge states (22) , it is possible that other strongly attached states may have similar properties. Moreover, because cross-bridge attachment is known to enhance TnC Ca 2ϩ affinity (23, 24) , fewer S-1-binding sites along the thin filament could decrease this enhancement.
Having shown that the inhibitory properties of CTnI are capable of being neutralized when the double mutant is present, it is appropriate to consider another molecular mechanism involved in reducing the contractile force. McKillop and Geeves (25) have proposed a three-state model that describes how the thin filament conformation regulates myosin accessibility. They define the three states as: open, which predominates when Ca 2ϩ and strongly bound cross-bridges are present; closed, which predominates when Ca 2ϩ but no strongly bound cross-bridges are present; and blocked, which predominates in the absence of Ca 2ϩ and strongly bound crossbridges. Based on the above model, the observed reduction in myofilament ATPase activation (CMF and RAM), force, and number of S-1-binding sites are consistent with the double mutant promoting a thin filament conformation that shifts the equilibrium to favor the closed state when saturating levels of Ca 2ϩ are present. Many investigators have found that Ca 2ϩ desensitization of cardiac muscle contraction is a common effect caused by DCM-linked mutations in the sarcomere. Notably, cardiac fibers from 13 idiopathic DCM patients also required higher Ca 2ϩ concentrations to generate their maximal ATPase activities and were unable to achieve the maximal ATPase response seen in nonfailing heart fibers (26) . Similar studies in conjunction with our findings suggest that the following mechanisms may contribute to the systolic dysfunction and larger end diastolic dimensions associated with DCM. The decrease (direct or indirect) in CTnC calcium affinity and fewer available S-1 actin-binding sites are predicted to synergistically: 1) lower the Ca 2ϩ -activated ATPase and tension, consequently reducing the ejection fraction in vivo; and 2) facilitate diastolic filling as a result of having fewer cross-bridges attached during the previous systole. These findings are consistent with the pathophysiology of DCM in man and may contribute to the compensatory dilation that occurs over time with this disease.
The diagnosis of family members affected with another CTnC mutation (G159D) associated with DCM ranged from 20 to 62 years of age with the pathogenicity ranging from moderate to severe (27, 28) . Although no segregation and penetrance data are available for the E59D/D75Y mutation, the variable penetrance associated with G159D suggests that CTnC mutations, like other sarcomeric mutations, are governed by multifactorial processes (i.e. modifier genes and epigenetic factors) (29) .
Although assigning pathogenicity of a mutation is often hindered by a lack of family studies showing segregation with disease, such information would be valuable; however, it is very difficult to obtain. Therefore, Hershberger et al. (30) have reasoned that relevant functional studies are extremely valuable in interpreting the molecular results of a mutation. Based upon this rationale, Hershberger et al. were able to assign three of five mutations in the gene encoding CTnT as likely causative agents of DCM in the absence of any family segregation data. Therefore, ongoing research that integrates molecular, clinical, and functional data are critical determinants of the significance of mutations. In conclusion, although studies showing segregation of the E59D/D75Y mutation with disease is not available, our data show that this mutation can recapitulate the DCM functional phenotype in vitro and provide support that this is likely a DCM-causing mutation.
